Valuation (21%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -1.01 | 12.13 |
PEG Ratio (TTM) | -0.03 | 1.18 |
P/S Ratio (TTM) | 0.76 | 4.74 |
P/B Ratio (TTM) | 1.41 | 3.47 |
P/FCF Ratio (TTM) | -1.23 | 21.28 |
Price to 5YR AVG Earnings Ratio | -0.10 | 31.63 |
Price to 5YR AVG FCF Ratio | -0.90 | 17.81 |
Profitability (25%) |
Company | Industry |
---|---|---|
ROA (TTM) | -43.43% | 3.40% |
ROE (TTM) | -308.51% | 10.53% |
Net Profit Margin (TTM) | -71.33% | -10.38% |
ROIC 5YR AVG | 406.88% | 7.71% |
Growth (45%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 26.96% | 4.27% | 9.18% |
Revenue | 15.46% | 2,309.67% | 1,418.11% |
Net Income | 4.85% | -16.25% | -6.92% |
Cash Flow | -17.74% | -27.98% | -2.58% |
Health (21%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.44 | 2.54 |
Quick Ratio (TTM) | 1.39 | 1.91 |
D/E Ratio (TTM) | 1.14 | -0.28 |
Interest Coverage (TTM) | -11.76 | 13.51 |
Piotroski F-Score | 3 | 6 |
Altman Z-Score | N/A | 4.97 |
LTL to 5YR AVG FCF | -0.69 | 4.03 |
Shares Outstanding Growth 5YR AVG | 19.69% | 28.69% |